abnormal B cell physiology_Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0

http://metadb.riken.jp/0002459IFVBNTgIghmCtla4IgCd801Jbs0TgIghmCtla4IgCd801Jbs

abnormal B cell physiology_Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Jeffery Bluestone
  http://metadb.riken.jp/db/mgi_rdf/MGI:3711770

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Ighm-Ctla4Ig/Cd80)1Jbs

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal B cell physiology
  http://purl.obolibrary.org/obo/MP_0002459

文献

http://purl.org/net/cito/citesAsAuthority

• Brian T. Fife, et.al., Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist., The Journal of clinical investigation, 2006, 116
  http://rdf.ncbi.nlm.nih.gov/pubmed/16886063